Follow this preprint
Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity
View ORCID ProfileJasmine M Gardner, View ORCID ProfileLander Willem, View ORCID ProfileWouter Van Der Wijngaart, View ORCID ProfileShina Caroline Lynn Kamerlin, View ORCID ProfileNele Brusselaers, View ORCID ProfilePeter Kasson
doi: https://doi.org/10.1101/2020.04.11.20062133
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Jasmine M Gardner
1Science for Life Laboratory, Department of Chemistry – BMC, Uppsala University, BMC Box 576, S-751 23 Uppsala, Sweden,
PhDRoles: Post-doc in Structural Biology
Lander Willem
2Centre for Health Economic Research and Modelling Infectious Diseases, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium,
PhDRoles: Post-doc in Infectious Disease Modelling
Wouter Van Der Wijngaart
3School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Malvinas väg 10, SE-100 44 Stockholm, Sweden,
PhDRoles: Professor in Engineering
Shina Caroline Lynn Kamerlin
4Science for Life Laboratory, Department of Chemistry – BMC, Uppsala University, BMC Box 576, S-751 23 Uppsala, Sweden,
PhDRoles: Professor of Structural Biology
Nele Brusselaers
5Centre for Translational Microbiome Research (CTMR), Dept. of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Sweden; Ghent University, Belgium,
MD MSc PhDRoles: Associate Professor in Clinical Epidemiology
Peter Kasson
6Science for Life Laboratory, Dept. of Cell and Molecular Biology, Uppsala University, Uppsala 75124 Sweden and Departments of Molecular Physiology and Biomedical Engineering, University of Virginia, USA,
MD PhDRoles: Associate Professor of Cell and Molecular Biology

Article usage
Picked up by 22 news outlets
Blogged by 3
Tweeted by 1778
On 1 Facebook pages
56 readers on Mendeley
Posted April 15, 2020.
Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity
Jasmine M Gardner, Lander Willem, Wouter Van Der Wijngaart, Shina Caroline Lynn Kamerlin, Nele Brusselaers, Peter Kasson
medRxiv 2020.04.11.20062133; doi: https://doi.org/10.1101/2020.04.11.20062133
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
23
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
25
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (411)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3093)
- Dermatology (261)
- Emergency Medicine (463)
- Epidemiology (13021)
- Forensic Medicine (13)
- Gastroenterology (860)
- Genetic and Genomic Medicine (4842)
- Geriatric Medicine (447)
- Health Economics (750)
- Health Informatics (3058)
- Health Policy (1103)
- Hematology (410)
- HIV/AIDS (957)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (499)
- Neurology (4609)
- Nursing (244)
- Nutrition (687)
- Oncology (2388)
- Ophthalmology (674)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (515)
- Pediatrics (1239)
- Primary Care Research (522)
- Public and Global Health (7191)
- Radiology and Imaging (1601)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (512)
- Toxicology (65)
- Transplantation (221)
- Urology (189)